Ezurpimtrostat autophagy blocker, a palmitoyl-protein thioesterase 1 (ppt1) inhibitor, and atezolizumab/bevacizumab triple combination regimen enhances antitumor efficacy in hepatocellular carcinoma
HEPATOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要